Dáil Éireann Debate, Thursday - 3 April 2014
244. Deputy Aengus Ó Snodaigh asked the Minister for Health if consideration has been given to making the new drug in the treatment of hepatitis C, Telebiron or Vivtielis available to sufferers in the State; and if he will make a statement on the matter. [15774/14]
Amharc ar fhreagra256. Deputy Aengus Ó Snodaigh asked the Minister for Health the reason the drugs Telebiron and Vivtielis are not available to hepatitis C sufferers; and if there are plans to make these drugs available in the future. [15858/14]
Amharc ar fhreagraI propose to take Questions Nos. 244 and 256 together.
It is assumed the Deputy is referring to Telaprevir (Incivo) and Victrelis (Boceprevir). These drugs are currently available via the Primary Care Reimbursement Service Hepatitis C Reimbursement System, when prescribed via the eight National designated Hepatitis C centres.
